Ann: Medgate extends European ResAppDx trial, page-32

I've found this news very positive too!

It seems like no one questions the app or the AI&ML tech architecture. the only concern is how to implement and use this tech in their established system and current way of working. it makes sense to me because there is no other example on the market they can refer to.

It's very similar when you buy a new software to your company, it needs trials, change management and dealing with the resistance that comes from the staff. Given this is a health sector, any little details become major concerns and needs to be fixed urgently before it's being used by patients and health professionals.

this is also win-win situation too. ResApp gets free consultation from Medgate and Medgate gets custom tailored software for their system and they will be the first telehealth company that offers this innovative technology to their customers globally.

IMHO we'll have some great news after this extended trial.